NEJM on X: "A single 25-mg dose of psilocybin was more effective than a 1-mg dose at alleviating treatment-resistant depression over a period of 3 weeks. The effect was attenuated at 12
Psychedelic microdosing benefits and challenges: an empirical codebook | Harm Reduction Journal | Full Text
Microdosing with psilocybin mushrooms: a double-blind placebo-controlled study | Translational Psychiatry
Microdosing with psilocybin mushrooms: a double-blind placebo-controlled study | Translational Psychiatry
Emotions and brain function are altered up to one month after a single high dose of psilocybin | Scientific Reports
How to dose psychedelic mushrooms | Pediatric and Adult Behavioral Counseling
Psilocybin rescues sociability deficits in an animal model of autism | bioRxiv
Psilocybin Revisited: The Science Behind the Drug and Its Surprising Therapeutic Potential
Psychedelic experience dose-dependently modulated by cannabis: results of a prospective online survey | Psychopharmacology
Psilocybin improves treatment-resistant depression, but linked to adverse events
Psilocybin mushrooms for psychological and existential distress | The College of Family Physicians of Canada
Frontiers | Therapeutic use of psilocybin: Practical considerations for dosing and administration
How to dose psychedelic mushrooms | Pediatric and Adult Behavioral Counseling
N.S. company launching clinical trial to examine magic mushrooms as treatment for PTSD | CBC News
How to dose psychedelic mushrooms | Pediatric and Adult Behavioral Counseling
Frontiers | Low Doses of Psilocybin and Ketamine Enhance Motivation and Attention in Poor Performing Rats: Evidence for an Antidepressant Property
Psilocybin: One Dose of Magic Mushroom Psychedelic Can Ease Major Depression - Bloomberg
Psychedelic Drug Therapy May Help Treat Alcohol Addiction | NYU Langone News
Study suggests single dose of psilocybin safe and effective as treatment for major depressive disorder
Frontiers | The Effects of Daytime Psilocybin Administration on Sleep: Implications for Antidepressant Action
Frontiers | Low Doses of Psilocybin and Ketamine Enhance Motivation and Attention in Poor Performing Rats: Evidence for an Antidepressant Property
Trial of Psilocybin versus Escitalopram for Depression | NEJM
Optimal dosing for psilocybin pharmacotherapy: Considering weight-adjusted and fixed dosing approaches - Albert Garcia-Romeu, Frederick S Barrett, Theresa M Carbonaro, Matthew W Johnson, Roland R Griffiths, 2021
